Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: Response to therapy and quality of life of patients

Journal of Neuro-Oncology

Volumn 43, Issue 3, 1999, Pages 259-268

  Guha Thakurta, Nandita ^a   Damek, Denise ^a   Pollack, Craig ^a   Hochberg, Fred H ^a  

^a NONE   (United States)

Author keywords

Brain tumor; Chemotherapy; Lymphoma; Methotrexate (MTX); PCNSL; QOL

Indexed keywords

ANTINEOPLASTIC AGENT; METHOTREXATE;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COPING BEHAVIOR; DRUG CLEARANCE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LYMPHOMA; MALE; MEMORY; MUCOSA INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROBLEM SOLVING; QUESTIONNAIRE; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; SYMPTOM; WELLBEING;

ACTUARIAL ANALYSIS; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; QUESTIONNAIRES; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0032848235     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006210703827     Document Type: Article

References (51)

1. Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr: Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79: 2409-2413, 1997
2. Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P, AIDS/Cancer Study Group: J Natl Cancer Inst 88: 675-679, 1996
3. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H: Pathology with clinical correlations of primary central nervous system/Non-Hodgkin's lymphoma. Cancer 74: 1383-1397, 1994
4. Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the U.S. Cancer 62: 2461-2465, 1988
5. Jellinger J, Radaskiewicz TH, Slowick F: Primary malignant lymphomas of the central nervous system in man. Acta Neuropathologica (Suppl 6): 95-102, 1975
6. Henry JM, Heffner RR, Dillard SH, Earle KM, Davis RL: Primary malignant lymphomas of the central nervous system: Cancer 34: 1293-1302, 1974
7. Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ: Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation rherapy oncology group (RTOG): TROG 8315. Int J Radiat Oncol Biol Phys 23: 9-17, 1992
8. Chamberlain MC, Levin VA: J Neuro-Oncol 14: 271-275, 1992
9. Shibamoto Y, Tsutsui K, Dodo Y, Yamabe H, Shima N, Abe M: Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65: 1907-1912, 1990
10. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939-947, 1989
11. Freeman CR, Shustik C, Brisson ML, Meagher-Villemure K, Dylewski I: Primary malignant lymphoma of the central nervous system. Cancer 58: 1106-1111, 1986
12. Abelson HT, Kufe DW, Skarin AT, Major P, Ensminger W, Beardsley GP, Cancellos GP: Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep 65(Supp1): 137-140, 1981
13. Crossen JR, Garwood D, Neuwelt EA: Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12: 627-642, 1994
14. Sheline G, Wara WM, Smith V: Therapeutic irradiation and brain injury. Int J Radiation Oncology Biol Phys 6: 1215-1228, 1980
15. Cher L, Glass J, Harsh GR, Hochberg FH: Therapy of primary central nervous system lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 46: 1757-1759, 1996
16. Freilich RJ, Delattre JY, Monjour A, DeAngelis LM: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46: 435-439, 1996
17. Glass J, Shustik C, Hochberg FH, Cher L, Gruber ML: Therapy of primary central nervous system lymphoma with preirradiation methotrexate, cyclophosphamide, doxorubicin, vincristine and dexamethasone (MCHOD). J Neuro-Oncol 30: 257-265, 1996
18. Glass J, Gruber ML, Cher L, Hochberg FH: Pre-irradiation MTX chemotherapy of primary central nervous system lymphoma: long term outcome. J Neurosurgery 81: 188-195, 1994
19. Lachance DH, Briezel DM, Gockerman JP, Halperin EC, Burger PC, Boyko OB, Brown MT, Schold SC Jr: Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multi-focal intracerebral recurrence preceding radiotherapy. Neurology 44: 1721-1727, 1994
20. DeAngelis LM, Yaholom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992
21. Schultz C, Scott C, Wasserman T, Fisher B, Abrams R, Sherman W, Fetell M, Nelson J: Pre-irradiation chemotherapy (CTX) with cytoxan, adriamycin, vincristine, and decadron (CHOD) for primary central nervous system lymphomas (PCNSL): Initial report of radiation therapy oncology group (RTOG) protocol 88-06. Proc Am Soc Clin Oncol 13: 174, 1994
22. Watne K, Scott H, Hager B, Lindegaard MW, Nome O, Abrahamsen AF, Hirschberg H: Primary malignant lymphoma of the brain: A report of 24 cases from the Norwegian radium hospital. Acta Oncol 31: 545-550, 1992
23. Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel Rita, Dana B: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580-1590, 1991
24. Bessell EM, Punt J, Firth J, Hope T, Holland I, Lowe J: Primary non-Hodgkin's lymphoma of the central nervous system: Phase II study of chemotherapy (BVAM) prior to radiotherapy. Clin Oncol (R Coll Radiol) 3: 193-198, 1991
25. Socié G, Piprot-Chauffat C, Schlienger M, Legars D, Thurel C, Mikol J, Ifran N, Briere J, Pene F, Gindrey-Vie B, Marin JL, Desablens B, Laugier A: Primary lymphoma of the central nervous system. Cancer 65: 322-326, 1990
26. Brada M, Dearnaley D, Horwich A, Bllom HJG: Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiation Oncology Biol Phys 18: 787-792, 1990
27. Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Holteman K: High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 70: 190-194, 1989
28. Stewart FJ, Russell N, Dennery J, Richard M, Atack E, Eapen L: Cyclophosphamide, adriamycin, vincristine, and dexamethasone in the treatment of bulky central nervous system lymphomas. J Neuro-Oncol 2: 289, 1984
29. Hoang-Xaun K, Chinot O, Frenay M, Taillandier L, Hildebrand J, Monjour A, Van den Bent M, Sahmoud T, Poisson M, Delattre JY: Chemotherapy alone as initial treatment of primary central nervous system lymphoma (PCNSL) in older patients. (Abstracts) Neurology 48: A17, 1997
30. 2 of intravenous methotrexate (IVMTX) for primary central nervous system lymphoma (PCNSL). (Abstracts) Neurology 48: A17-18, 1997
31. Kaplan E, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481, 1958
32. Mackworth N, Fobair P, Prados MD: Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neuro-Oncol 14: 243-253, 1992
33. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA: The functional assessment of cancer therapy (FACT) scale: Development of a brain subscale and the revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75: 1151-1161, 1995
34. Kellner R: A symptom questionnaire. J Clin Psychiatry 48: 268-274, 1987
35. Kellner R, Abbott P, Pathak D, Winslow WW, Umland BE: Hypochondriacal beliefs and attitudes in family practice and psychiatric patients. Int J Psychiatry Med 13: 127-139, 1984
36. Weissman MM, Bothwell S: Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 33: 1111-1115, 1976
37. Weissman MM, Pusoff BA, Thompson WD, Harding PS, Myers JK: Social adjustment by self-report in a community sample in psychiatric outpatients. J Nervous Mental Disease 166: 317-326, 1978
38. Heppner PP, Petersen CH: The development and implications of a personal problem-solving inventory. J Counseling Psychology 29: 66-75, 1982
39. Heppner PP, Baker CE: Assessment in action: Applications of the problem solving inventory. Measurement and evaluation in counseling and development 29: 229-241, 1997
40. Heppner PP: The problem solving inventory: manual. Consulting Psychologists Press, Palo Alto, CA, 1988, pp 5
41. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state' - A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12: 189-198, 1975
42. Kokmen E, Smith GE, Peterson RC, Tangalos E, Ivnik RC: The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol 48: 725-728, 1991
43. Packer RJ, Zimmerman RA, Bilaniuk LT: Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 58: 635-640, 1986
44. Allen JC, Rosen G, Mehta BM, Horten BH: Leuko-encephalopathy following high-dose IV methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64: 1261-1273, 1980
45. Skullerud K, Halvorsen K: Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia; Cancer 42: 1211-1215, 1978
46. Robinson JK, Boshier ML, Dansak DA, Peterson KJ: Depression and anxiety in cancer patients: Evidence for different causes. J Psychosomatic Res 29: 133-138, 1985
47. Crossen JR, Goldman D, Dahlborg SA, Neuwelt EA: Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery 30: 23-29, 1992
48. Kay HEM, Knapton PJ, O'Sullivan JP, Wells DG, Harris RF, Innes EM, Stuart J, Schwartz FCM, Thompson EN: Encephalopathy in acute leukemia associated with methotrexate therapy. Arch Disease in Childhood 47: 344-354, 1972
49. Kramer S: The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15: 301-318, 1968
50. Chamberlain MC, Levin VA: Arch Neurol 47: 1113-1116, 1990
51. Abrey LE, Yahalom J, DeAngelis LM: Relapse and late neurotoxicity in primary central nervous system lymphoma (PCNSL). (Abstracts) Neurology 48: A18, 1997